JP2004535178A5 - - Google Patents

Download PDF

Info

Publication number
JP2004535178A5
JP2004535178A5 JP2002587594A JP2002587594A JP2004535178A5 JP 2004535178 A5 JP2004535178 A5 JP 2004535178A5 JP 2002587594 A JP2002587594 A JP 2002587594A JP 2002587594 A JP2002587594 A JP 2002587594A JP 2004535178 A5 JP2004535178 A5 JP 2004535178A5
Authority
JP
Japan
Prior art keywords
sodium channel
polypeptide
nucleic acid
isolated
epilepsy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
JP2002587594A
Other languages
English (en)
Japanese (ja)
Other versions
JP2004535178A (ja
Filing date
Publication date
Priority claimed from AUPR4922A external-priority patent/AUPR492201A0/en
Application filed filed Critical
Publication of JP2004535178A publication Critical patent/JP2004535178A/ja
Publication of JP2004535178A5 publication Critical patent/JP2004535178A5/ja
Abandoned legal-status Critical Current

Links

JP2002587594A 2001-05-10 2002-05-09 新規変異 Abandoned JP2004535178A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AUPR4922A AUPR492201A0 (en) 2001-05-10 2001-05-10 Novel mutation
PCT/AU2002/000581 WO2002090532A1 (en) 2001-05-10 2002-05-09 Novel mutation

Publications (2)

Publication Number Publication Date
JP2004535178A JP2004535178A (ja) 2004-11-25
JP2004535178A5 true JP2004535178A5 (cg-RX-API-DMAC7.html) 2005-08-18

Family

ID=3828909

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2002587594A Abandoned JP2004535178A (ja) 2001-05-10 2002-05-09 新規変異

Country Status (6)

Country Link
US (1) US20040191791A1 (cg-RX-API-DMAC7.html)
EP (1) EP1385945A4 (cg-RX-API-DMAC7.html)
JP (1) JP2004535178A (cg-RX-API-DMAC7.html)
AU (1) AUPR492201A0 (cg-RX-API-DMAC7.html)
CA (1) CA2446838A1 (cg-RX-API-DMAC7.html)
WO (1) WO2002090532A1 (cg-RX-API-DMAC7.html)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1407013B1 (en) 2001-07-18 2007-09-12 Bionomics Limited Mutations in ion channels
WO2008079412A2 (en) * 2006-12-22 2008-07-03 The Trustees Of Columbia University In The City Of New York Methods and compositions to treat arrhythmias
CN117821509A (zh) 2017-04-03 2024-04-05 编码治疗公司 组织选择性转基因表达
CN118345115A (zh) 2017-12-01 2024-07-16 编码治疗公司 工程化的dna结合蛋白
SG11202113048SA (en) 2019-05-29 2021-12-30 Encoded Therapeutics Inc Compositions and methods for selective gene regulation
WO2024038160A1 (en) * 2022-08-18 2024-02-22 Vib Vzw Means and methods to modulate neuron excitability

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1171589A1 (en) * 1999-04-15 2002-01-16 Cambridge University Technical Services Limited A novel family of beta sub-unit proteins from a voltage-gated sodium channel, nucleic acids encoding them and therapeutic or diagnostic uses thereof
AU1846501A (en) * 1999-11-26 2001-06-04 Bionomics Limited Loci for idiopathic generalized epilepsy, mutations thereof and method using same to assess, diagnose, prognose or treat epilepsy

Similar Documents

Publication Publication Date Title
JP6904707B2 (ja) ヒト化プログラム細胞死1遺伝子を持つ非ヒト動物
Lee et al. Human C5aR knock-in mice facilitate the production and assessment of anti-inflammatory monoclonal antibodies
KR102073034B1 (ko) 항cxcr3 항체
Pullen et al. Pharmacological characterization of PF‐00547659, an anti‐human MAdCAM monoclonal antibody
EP2021016B1 (en) Cxcl-13 antagonists and tnf-alpha antagonists for use in a combination therapy
SK4512002A3 (en) April-r antagonist for the treatment of diseases related to undesirable cell proliferation
RS56268B1 (sr) Monoklonalno antitelo protiv interleukina-31 kod pasa
JPH10510709A (ja) 摂食行動を変える方法、該方法に有用な化合物、および視床下部の異型神経ペプチドy/ペプチドyy受容体(y5)をコードするdna
WO2005070965A2 (en) Pharmaceutical compositions containing antagonists to lrp4, lrp8 or megalin for treatment of diseases
US20050014687A1 (en) Therapeutic polypeptides, nucleic acids encoding same, and methods of use
JP2015187135A (ja) 神経疾患の処置方法
EP1351968B1 (en) Sodium-channel alpha1-subunit and their polypeptides and their treatment of generalised epilepsy with febrile seizures plus
CA2454073A1 (en) Mutations in ion channels
JP2004500126A5 (cg-RX-API-DMAC7.html)
JP2006524490A5 (cg-RX-API-DMAC7.html)
CN105764527A (zh) 新b细胞细胞因子的鉴定
US20110123535A1 (en) Use of Nogo Receptor-1 (NGR1) for Promoting Oligodendrocyte Survival
JP2004500126A (ja) てんかんに関係する突然変異
WO2022093641A1 (en) Anti-nkg2a agents and compositions and methods for making and using the same
JP2007501601A5 (cg-RX-API-DMAC7.html)
EP1991577A2 (en) Modulation of mdl-1 activity for treatment of inflammatory disease
WO2006068326A1 (ja) 新規ポリペプチドおよびその用途
JP2004535178A (ja) 新規変異
US7709225B2 (en) Nucleic acids encoding mutations in sodium channels related to epilepsy
WO2002064787A1 (fr) Neurotonine et utilisation